GlassScriptPhysician profile
Yolonda M Smith
NPI 1386777050
$313.84
in general payments reported to CMS, 2019-2025
11 companies · $66.83 in 2025
The $66.83 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $25.71 · 2021: $16.53 · 2022: $52.55 · 2025: $66.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $66.83 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Allergan, INC. | $44.01 | 2019-2020 | |
| Abbvie INC. | $36.94 | 2021-2022 | |
| Therapeuticsmd, INC. | $33.98 | 2019 | |
| Roche Diagnostics Corporation | $31.80 | 2019 | |
| Merck Sharp & Dohme LLC | $27.45 | 2019-2020 | |
| Coopersurgical, INC. | $19.95 | 2022 | |
| Boston Scientific Corporation | $15.76 | 2019 | |
| Hologic Sales and Service, LLC | $12.72 | 2019 | |
| Lupin INC. | $12.21 | 2019 | |
| Avion Pharmaceuticals | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolonda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.